First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker

BACKGROUND: A disintegrin and metalloprotease 12 (ADAM12-S) has previously been reported to be significantly reduced in maternal serum from women with fetal aneuploidy early in the first trimester and to significantly improve the quality of risk assessment for fetal trisomy 21 in prenatal screening....

Descripción completa

Detalles Bibliográficos
Autores principales: Tørring, Niels, Ball, Susan, Wright, Dave, Sarkissian, Gaïané, Guitton, Marie, Darbouret, Bruno
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984461/
https://www.ncbi.nlm.nih.gov/pubmed/21034452
http://dx.doi.org/10.1186/1477-7827-8-129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984461/
https://www.ncbi.nlm.nih.gov/pubmed/21034452
http://dx.doi.org/10.1186/1477-7827-8-129

Ejemplares similares